BlackRock, Inc. 13D and 13G filings for Vaxcyte, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-25 1:48 pm Purchase | 2023-12-31 | 13G | Vaxcyte, Inc. PCVX | BlackRock Inc. BLK | 8,575,238 9.000% | 3,469,868 (+67.97%) | Filing |
| 2023-02-03 12:10 pm Purchase | 2022-12-31 | 13G | Vaxcyte, Inc. PCVX | BlackRock Inc. BLK | 5,105,370 6.500% | 2,316,363 (+83.05%) | Filing |
| 2022-03-09 5:18 pm Purchase | 2022-02-28 | 13G | Vaxcyte, Inc. PCVX | BlackRock Inc. BLK | 2,789,007 5.000% | 11,960 (+0.43%) | Filing |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Vaxcyte, Inc. PCVX | BlackRock Inc. BLK | 2,777,047 5.300% | 2,777,047 (New Position) | Filing |